CbdMD Financials
| YCBD-PA Preferred Stock | USD 0.80 0.07 9.59% |
CbdMD |
Understanding current and past CbdMD Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CbdMD's financial statements are interrelated, with each one affecting the others. For example, an increase in CbdMD's assets may result in an increase in income on the income statement.
Please note, the presentation of CbdMD's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CbdMD's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CbdMD's management manipulating its earnings.
CbdMD Preferred Stock Summary
CbdMD competes with CbdMD, FAT Brands, Fortress Biotech, HUMANA, and Barloworld. cbdMD, Inc. produces and distributes various cannabidiol products. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina. CbdMD Inc is traded on ASE Exchange in the United States.Specialization | Healthcare, Drug Manufacturers - Specialty & Generic |
| Instrument | USA Preferred Stock View All |
| Exchange | New York Stock Exchange |
| CUSIP | 12482W200 |
| Location | North Carolina; U.S.A |
| Business Address | 8845 Red Oak |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.cbdmd.com |
| Phone | 704 445 3060 |
| Currency | USD - US Dollar |
CbdMD Key Financial Ratios
CbdMD's financial ratios allow both analysts and investors to convert raw data from CbdMD's financial statements into concise, actionable information that can be used to evaluate the performance of CbdMD over time and compare it to other companies across industries.| Return On Equity | -1.04 | ||||
| Return On Asset | -0.13 | ||||
| Number Of Employees | 90 | ||||
| Beta | 2.24 | ||||
| Z Score | -3.3 |
CbdMD Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CbdMD's current stock value. Our valuation model uses many indicators to compare CbdMD value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CbdMD competition to find correlations between indicators driving CbdMD's intrinsic value. More Info.cbdMD Inc is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value CbdMD by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CbdMD's Preferred Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.cbdMD Inc Systematic Risk
CbdMD's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CbdMD volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on cbdMD Inc correlated with the market. If Beta is less than 0 CbdMD generally moves in the opposite direction as compared to the market. If CbdMD Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one cbdMD Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CbdMD is generally in the same direction as the market. If Beta > 1 CbdMD moves generally in the same direction as, but more than the movement of the benchmark.
CbdMD Thematic Clasifications
cbdMD Inc is part of Consumer Goods investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Consumer Goods industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Consumer Goods industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Consumer Goods | View |
CbdMD December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CbdMD help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of cbdMD Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of cbdMD Inc based on widely used predictive technical indicators. In general, we focus on analyzing CbdMD Preferred Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CbdMD's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.88 | |||
| Information Ratio | 0.1717 | |||
| Maximum Drawdown | 36.89 | |||
| Value At Risk | (6.76) | |||
| Potential Upside | 15.63 |
Complementary Tools for CbdMD Preferred Stock analysis
When running CbdMD's price analysis, check to measure CbdMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CbdMD is operating at the current time. Most of CbdMD's value examination focuses on studying past and present price action to predict the probability of CbdMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CbdMD's price. Additionally, you may evaluate how the addition of CbdMD to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |